Matthew Byerly, M.D.

Professional Background

Matthew J. Byerly, MD, is a board-certified psychiatrist who has broad expertise in clinical and translational mental health research, which he applies to projects related to suicide prevention/mental health promotion and schizophrenia. For 18 years, Dr. Byerly directed the Schizophrenia and Adult Fragile X Research Programs at UT Southwestern Medical Center where he became a leader in research related to medication adherence, having developed the internationally recognized Brief Adherence Rating Scale (BARS). From 2015-2018, Dr. Byerly steered the Center for Mental Health Research and Recovery at Montana State University where he focused on addressing suicide and mental health challenges in rural communities.

Dr. Byerly has led or co-led more than 45 clinical trials funded by the NIMH, and state, and industry sponsors. He has served on multiple Scientific Advisory Boards including the Food and Drug Administration Psychopharmacologic Drugs Advisory Committee and the NIMH CATIE Trial. As an educator, Dr. Byerly has mentored many clinicians and early psychiatric researchers. For 10 years, he served as an NIMH-funded Psychiatric Research Education Program (PREP) Director and Associate Residency Training Director for Didactics and Research.

Dr. Byerly currently trains students and residents in supervised care and through didactics and conducts research at the University of Kansas Medical Center - Wichita.